1

STAAR Visian ICL State-of-the-art Vision Correction

June, 2015Kyiv

S. T. A. A. R. Surgical

• Surgical

• Technology

• And

• Advanced

• Research

STAAR Surgical worldwide

HQ USAIntl HQ Switzerland Fastest growing

markets: Asia

ICL MFG

The ICL - History• 1991 First implantations (Fyodorov, Russia)• 1993 First modern STAAR ICL implanted (Pesando, Italy) V1-V3• 1997 CE marking and official launch • 1998 Latest design V4• 2002 CE Marking Toric• 2005 US FDA Approval• 2010 Approval in Japan• 2011 CE marking V4C• 2013 >400k lenses implanted worldwide !• 2014 CE marking China

Proven Safety Record>500k lenses implanted globally>100k Visian Toric ICLs implanted globallyVisian ICL V4C approved in every major

refractive market (EU, China, Korea, Japan, Brazil, India)

The Visian ICL has a track record of stable, consistently excellent clinical outcomes.

Currently sold in more than 90 countries

Posterior Chamber location Safe distance from the endothelium Cosmetically invisible for patient Gain in retinal image size, increased magnification for patient Greater effective Optical Zone at the corneal plane

Sulcus Location Stable location allowing for Toric design Easily removable /exchangable No fixation to surrounding tissues Does not alter shape/remove tissue maintaining

treatment flexibility for the future Does not induce dry eye.

Visian ICL® Details

What is the ICL ?

• The ICL can correct:– Nearsightedness (Myopia)– Farsightedness (Hyperopia)– Astigmatism

One of the widest treatment ranges of any refractive product:

From -0.5D to -18.0D Spherical correctionFrom +0.5D to +10.0D Spherical CorrectionFrom 0.5D to 6.0D of Astigmatism correction

Made of Collamer®: Collagen and HEMA copolymer Excellent biocompatibility resulting in quiet eyes Excellent transmittance and low reflectance patterns (no haloes

or glare) UV chromophore which may help protect the retina from UV rays Very flexible (foldable, small incision, easy to inject, remove)

Visian ICL® Product Details

Why COLLAMER?• Soft and foldable and inserted through micro-incision

Quicker visual recovery

• Because of the biocompatibility, the ICL is not recognized as a foreign body

Happy Eyes after surgery

• Collamer contains a UV filter which protects against the negative effect of the sun on the crystalline lens and the retina.

Protection of crystalline lens and retina

< 100 um

< 50 microns

500-600 um

ICL is Very Thin

Made of proprietary biocompatible Collamer material

Central Optic port of 360µ, eliminates the need for PI’s

Also has Extended alignment markings on the Toric model

Visian ICL with CentraFLOW

>100.000 implants

Advantages of ICLThe central cornea remains entirely untouched

Dry eyes complications do not occur

Super Optical clarity of a lens-based additive surgery, rather than a tissue procedure

My patient will have a “HD Vision” outcome without as much of the glare and halos often seen with LVC

Advantages of ICL

Should my patient not like their vision, the ICL can be removed

Subsequent IOL calculations for cataract surgery (when the patient is older) will not be affected since there has been no corneal refractive procedure

Visual recovery is rapid

Growing indications

• Moderate to high myopia• Patients with high expectations (HD-

Vision, need for better night vision)• Patients with thin corneas• Patients with irregular corneas (Stable KC)• Patients with large pupils

Contraindications

• Glaucoma• Cataract, early or advanced• ACD less than 2.8mm• Age over 45• Non-stable KC

Benefits of ICL

• Wide range of correction (safe and effective also for very high degrees!)

• Superior quality of vision• Better predictability (no healing!) and stability (no

regression!)• Better night vision• Faster recovery• No tissue is permanently removed from the cornea• Removable (reversibility of the surgery)• Eye remains unchanged for future procedures!

4 Company Confidential

Thank you!!